Trials / Completed
CompletedNCT03970941
Two-stage Treatment of Large Bone Defects With Cerament® G and Cerament® V Plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy After Bone Resection in Patients With Septic Pseudarthrosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Septic pseudarthrosis of long bones are complications that can unfortunately occur after the consolidation of a fracture and some situations present risks of superinfection, persistent infection or mechanical failure (30-40% risk of complications) that can lead to amputation. A possible saving situation used by CRIOAC ("Centre de Référence des Infections Ostéo-Articulaires Complexes") is the use of a bone substitute impregnated with an antibiotic allowing a high local concentration of this antibiotic. The aim of this study is to evaluate the cost of management of septic pseudarthrosis with two-stage treatment and CERAMENT® and the quality of life for this patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cost evaluation | The cost for the hospital of the strategy of management will be evaluated. |
| OTHER | Questionnaire | The quality of life of patients will be measured. |
Timeline
- Start date
- 2019-09-05
- Primary completion
- 2022-12-21
- Completion
- 2022-12-21
- First posted
- 2019-06-03
- Last updated
- 2024-12-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03970941. Inclusion in this directory is not an endorsement.